Fertin Pharma A/S is awarded another issued patent on one-layered compressed nicotine gum


VEJLE, Denmark, March 09, 2018 (GLOBE NEWSWIRE) -- The market leading nicotine gum manufacturer, Fertin Pharma A/S, adds another milestone in the protection of compressed nicotine gum. While Fertin Pharma A/S has already obtained a large and complex patent portfolio on compressed two-layered nicotine gum, the new patent issued by the European Patent Office is believed to strengthen the competitive landscape in the segment of one-layered compressed nicotine gum. Fertin Pharma A/S has been issued numerous patents on this technology within the past decade. Now, Fertin Pharma A/S is the nicotine manufacturer with the largest patent portfolio on compressed nicotine gum.

Vice President of BD, Marketing & Sales, Anders Dam Vestergaard, announces that Fertin Pharma A/S would enforce the patent rights against any competitor infringing the patents in the field of one-layered compressed nicotine gum. This includes the newly issued patent, EP 2 229 158 B1, and other patents relevant for one-layered compressed gum technology. "It is fairly easy to detect infringement of our patent rights, and we have a close eye on our competitors in this field of technology," says Anders Dam Vestergaard. "In addition, we believe that our complex patent portfolio makes it difficult for our competitors to even enter this technology segment without infringing our patent rights," Anders Dam Vestergaard adds.

Further to the newly issued European patent, Fertin Pharma A/S has been issued a number of US and Indian patents with relevance in the field of one-layered compressed nicotine technology. These include US 8,603,440, US 8,722,022, US 8,524,196 and US 8,529,875.

Fertin Pharma A/S's main premises are located in Vejle, Denmark, with additional facilities in India. Fertin Pharma A/S is considered one of the world leading developers and manufacturers of B2B nicotine chewing gum .

For further information, please contact:
Anders Dam Vestergaard
Tel. +45 7215 1300

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Fertin Pharma A/S via Globenewswire




Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

3Gtms Positioned in the Niche Players Quadrant of the Gartner Magic Quadrant for Transportation Management Systems21.3.2018 15:00Pressmeddelande

Inclusion marks the first time 3Gtms has been named to the Magic Quadrant SHELTON, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- 3Gtms, Inc., a global provider of Tier 1 transportation management software, today announced it has been positioned by Gartner, Inc. in the Niche Players quadrant of the report, Magic Quadrant for Transportation Management Systems*. This is the first time 3Gtms has been positioned within the Magic Quadrant. According to the report, the research "focuses on holistic multimodal domestic TMSs for use by shippers (such as manufacturers, retailers, distributors and wholesalers) or non-asset-based, third-party logistics (3PL) organizations." Key criteria for the 2018 Magic Quadrant included: The breadth of the TMS; depth of the TMS; usability and adaptability; global go-to market strategy and offering; partner ecosystem; vision, thought leadership, roadmap, and track record; and a compelling SCE convergence strategy. The full report is available at no charge at the 3Gt

Further UHNWI Investment To Support FinTech Entrepreneur Zichain's Growth and Innovation21.3.2018 14:46Pressmeddelande

Zichain / Further UHNWI Investment To Support FinTech Entrepreneur Zichain's Growth and Innovation . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. ZURICH, Switzerland, March 21, 2018 (GLOBE NEWSWIRE) -- Zichain, a Switzerland-based digital asset management company, is pleased to announce that it has secured an USD 1.2m investment from a syndicate of UHNW Hong-Kong based investors, supporting further development of its unique cryptocurrency products. The deal was confirmed while the Company was participating at the Goldman Sachs 2018 Disruptive Technology Symposium, held in London on 20-21 March. As a pioneer of the cryptocurrency index industry, Zichain has enjoyed exponential growth with the Company now taking a leading role in the creation of digital asset management industry. Zichain is focused on the development of three key products: Blockchain Asset Management Platform (BAMP), a unique and convenien

Addivant Announces Price Increases on Hindered Amine Light Stablizers21.3.2018 14:38Pressmeddelande

DANBURY, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Effective immediately or as contract terms allow, Addivant(TM), a global leader in polymer additives, is increasing the price of Hindered Amine Light Stabilizers by up to 15%. The adjustment is driven by raw material cost increases and market conditions. About Addivant(TM) Addivant(TM) is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors and intermediates. Addivant is an international company, with 11 plants in five regions as well as research, manufacturing and sales facilities around the globe. Addivant maintains its global headquarters in Connecticut, USA with regional headquarters in: Al J

VistaJet Connects Customers and Their Passions With the Global British Polo Day Tour21.3.2018 14:17Pressmeddelande

Customers to join the most prestigious worldwide polo tournament LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- VistaJet, the first and only global private aviation company, will be offering customers the opportunity to enrich their passion for polo as the company partners with British Polo Day for the 2018 worldwide tournament, following a successful inaugurate partnership last year. The sport is a key interest for many of VistaJet's customers, both as spectators and riders, and is in line with 39% of the world's animal-loving Ultra High Net Worth population having a passion for horses*. VistaJet continuously develops and offers exceptional experiences for its customers inspired by their true passions, including art, sport and travel, across all cultures worldwide. Its global partnership with British Polo Day will offer customers an exclusive opportunity to enjoy one of their most cherished interests by watching some of the sport's top players, including the world's number one player Adol

Immunicum AB: Invitation to Investor Events21.3.2018 14:00Pressmeddelande

Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that the Company will host two investor events in April. At both events, Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Stockholm Date: Wednesday, April 11, 2018 Time: 18:00 - 20:00 CET Location: Citykonferensen Ingenjörshuset Room: Styrelserummet Malmskillnadsgatan 46 111 84 Stockholm Gothenburg Date: Wednesday, April 18, 2018 Time: 18:00 - 20:00 CET Location: First Hotel G Restaurant Orkidé Nils Ericsonplatsen 4 411 03 Gothenburg To register to attend the events, please send an email to with your full name and the selected location (Stockholm or Gothenburg). For more information, please contact:

Immunicum AB: Inbjudan till investerarkvällar21.3.2018 14:00Pressmeddelande

Pressmeddelande 21 mars 2018 Immunicum AB: Inbjudan till investerarkvällar Immunicum AB (IMMU.ST), ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörformer, meddelade idag att bolaget kommer att ordna två investerarkvällar i april. Vid båda tillfällena kommer Immunicums VD Carlos de Sousa att hålla en presentation av det dagsaktuella läget i bolaget, och han och övriga medlemmar i ledningen är tillgängliga för att svara på frågor. Stockholm Datum: onsdag, 11 april 2018 Tid: 18:00-20:00 CET Plats: Citykonferensen Ingenjörshuset Sal: Styrelserummet Malmskillnadsgatan 46 111 84 Stockholm Göteborg Datum: onsdag, 18 april 2018 Tid: 18:00-20:00 CET Plats: First Hotel G Sal: Orkidé i restaurangen Nils Ericsonplatsen 4 411 03 Göteborg För att delta i investerarkvällarna, skicka ett mejl till med ditt fullständiga namn och orten där du vill delta (Stockholm eller Göteborg). För ytterligare information kontakta: Carlos de So

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum